Plymouth Industrial REIT, Inc. (PLYM-PA) Stock Competitors & Peer Comparison
See (PLYM-PA) competitors and their performances in Stock Market.
Peer Comparison Table: REIT - Industrial Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PLYM-PA | $24.98 | +0.01% | 186.6M | -27.36 | -$0.91 | +2.18% |
| PLD | $139.36 | -0.05% | 130.7B | 25.78 | $5.44 | +2.98% |
| DLR | $172.92 | -0.22% | 62.1B | 38.95 | $4.46 | +2.82% |
| PSA-PG | $20.24 | +0.80% | 58.4B | 1.97 | $10.28 | +3.64% |
| PSA-PL | $18.05 | +0.84% | 58.4B | 1.76 | $10.28 | +3.64% |
| PSA-PR | $15.58 | +0.69% | 58.3B | 1.52 | $10.28 | +3.64% |
| PSA-PM | $16.00 | +0.45% | 58.3B | 1.56 | $10.28 | +3.64% |
| PSA-PQ | $15.33 | +0.66% | 58.3B | 1.49 | $10.28 | +3.64% |
| PSA-PS | $15.99 | +0.63% | 58.2B | 1.56 | $10.28 | +3.64% |
| PSA-PJ | $18.18 | +0.55% | 58.2B | 1.77 | $10.28 | +3.64% |
Stock Comparison
PLYM-PA vs PLD Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PLD has a market cap of 130.7B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PLD trades at $139.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PLD's P/E ratio is 25.78. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PLD's ROE of +0.07%. Regarding short-term risk, PLYM-PA is less volatile compared to PLD. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PLD's competition here
PLYM-PA vs DLR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, DLR has a market cap of 62.1B. Regarding current trading prices, PLYM-PA is priced at $24.98, while DLR trades at $172.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas DLR's P/E ratio is 38.95. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to DLR's ROE of +0.06%. Regarding short-term risk, PLYM-PA is less volatile compared to DLR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check DLR's competition here
PLYM-PA vs PSA-PG Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PG has a market cap of 58.4B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PG trades at $20.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PG's P/E ratio is 1.97. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PG's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PG. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PG's competition here
PLYM-PA vs PSA-PL Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PL has a market cap of 58.4B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PL trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PL's P/E ratio is 1.76. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PL's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PL. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PL's competition here
PLYM-PA vs PSA-PR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PR has a market cap of 58.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PR trades at $15.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PR's P/E ratio is 1.52. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PR's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PR's competition here
PLYM-PA vs PSA-PM Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PM has a market cap of 58.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PM trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PM's P/E ratio is 1.56. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PM's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PM. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PM's competition here
PLYM-PA vs PSA-PQ Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PQ has a market cap of 58.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PQ trades at $15.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PQ's P/E ratio is 1.49. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PQ's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PQ. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PQ's competition here
PLYM-PA vs PSA-PS Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PS has a market cap of 58.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PS trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PS's P/E ratio is 1.56. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PS's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PS. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PS's competition here
PLYM-PA vs PSA-PJ Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PJ has a market cap of 58.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PJ trades at $18.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PJ's P/E ratio is 1.77. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PJ's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PJ. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PJ's competition here
PLYM-PA vs PSA-PI Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PI has a market cap of 58.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PI trades at $19.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PI's P/E ratio is 1.85. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PI's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PI. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PI's competition here
PLYM-PA vs PSA-PO Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PO has a market cap of 58.1B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PO trades at $15.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PO's P/E ratio is 1.48. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PO's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PO. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PO's competition here
PLYM-PA vs PSA-PF Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PF has a market cap of 58B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PF trades at $20.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PF's P/E ratio is 1.98. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PF's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PF. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PF's competition here
PLYM-PA vs PSA-PN Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PN has a market cap of 58B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PN trades at $15.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PN's P/E ratio is 1.47. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PN's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PN. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PN's competition here
PLYM-PA vs PSA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA has a market cap of 56.9B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA trades at $323.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA's P/E ratio is 23.30. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA's competition here
PLYM-PA vs PSA-PK Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PK has a market cap of 47.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PK trades at $18.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PK's P/E ratio is 1.81. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PK's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PK. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PK's competition here
PLYM-PA vs PSA-PH Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PH has a market cap of 45.5B. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PH trades at $21.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PH's P/E ratio is 2.14. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PH's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PH. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PH's competition here
PLYM-PA vs EXR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, EXR has a market cap of 30.9B. Regarding current trading prices, PLYM-PA is priced at $24.98, while EXR trades at $145.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas EXR's P/E ratio is 22.04. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to EXR's ROE of +0.07%. Regarding short-term risk, PLYM-PA is less volatile compared to EXR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check EXR's competition here
PLYM-PA vs EGP Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, EGP has a market cap of 11.4B. Regarding current trading prices, PLYM-PA is priced at $24.98, while EGP trades at $212.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas EGP's P/E ratio is 24.71. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to EGP's ROE of +0.08%. Regarding short-term risk, PLYM-PA is less volatile compared to EGP. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check EGP's competition here
PLYM-PA vs LSI Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, LSI has a market cap of 11.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while LSI trades at $133.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas LSI's P/E ratio is 30.95. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to LSI's ROE of +0.07%. Regarding short-term risk, PLYM-PA is less volatile compared to LSI. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check LSI's competition here
PLYM-PA vs LINE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, LINE has a market cap of 9.9B. Regarding current trading prices, PLYM-PA is priced at $24.98, while LINE trades at $43.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas LINE's P/E ratio is -70.15. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to LINE's ROE of -0.02%. Regarding short-term risk, PLYM-PA is less volatile compared to LINE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check LINE's competition here
PLYM-PA vs CUBE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, CUBE has a market cap of 9.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while CUBE trades at $40.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas CUBE's P/E ratio is 15.65. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to CUBE's ROE of +0.12%. Regarding short-term risk, PLYM-PA is less volatile compared to CUBE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check CUBE's competition here
PLYM-PA vs REXR-PB Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, REXR-PB has a market cap of 8.8B. Regarding current trading prices, PLYM-PA is priced at $24.98, while REXR-PB trades at $22.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas REXR-PB's P/E ratio is 23.82. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to REXR-PB's ROE of +0.03%. Regarding short-term risk, PLYM-PA is less volatile compared to REXR-PB. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check REXR-PB's competition here
PLYM-PA vs FR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, FR has a market cap of 8.4B. Regarding current trading prices, PLYM-PA is priced at $24.98, while FR trades at $62.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas FR's P/E ratio is 18.70. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to FR's ROE of +0.13%. Regarding short-term risk, PLYM-PA is less volatile compared to FR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check FR's competition here
PLYM-PA vs REXR-PC Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, REXR-PC has a market cap of 8B. Regarding current trading prices, PLYM-PA is priced at $24.98, while REXR-PC trades at $21.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas REXR-PC's P/E ratio is 22.41. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to REXR-PC's ROE of +0.03%. Regarding short-term risk, PLYM-PA is less volatile compared to REXR-PC. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check REXR-PC's competition here
PLYM-PA vs REXR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, REXR has a market cap of 7.9B. Regarding current trading prices, PLYM-PA is priced at $24.98, while REXR trades at $34.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas REXR's P/E ratio is 15.86. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to REXR's ROE of +0.03%. Regarding short-term risk, PLYM-PA is less volatile compared to REXR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check REXR's competition here
PLYM-PA vs STAG Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, STAG has a market cap of 7.5B. Regarding current trading prices, PLYM-PA is priced at $24.98, while STAG trades at $39.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas STAG's P/E ratio is 15.10. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to STAG's ROE of +0.07%. Regarding short-term risk, PLYM-PA is less volatile compared to STAG. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check STAG's competition here
PLYM-PA vs TRNO Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, TRNO has a market cap of 7.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while TRNO trades at $68.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas TRNO's P/E ratio is 24.27. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to TRNO's ROE of +0.10%. Regarding short-term risk, PLYM-PA is less volatile compared to TRNO. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check TRNO's competition here
PLYM-PA vs JAN Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, JAN has a market cap of 6.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while JAN trades at $29.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas JAN's P/E ratio is -81.63. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to JAN's ROE of -0.04%. Regarding short-term risk, PLYM-PA is less volatile compared to JAN. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check JAN's competition here
PLYM-PA vs COLD Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, COLD has a market cap of 4.6B. Regarding current trading prices, PLYM-PA is priced at $24.98, while COLD trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas COLD's P/E ratio is -41.33. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to COLD's ROE of -0.04%. Regarding short-term risk, PLYM-PA is less volatile compared to COLD. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check COLD's competition here
PLYM-PA vs RCC Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, RCC has a market cap of 4.1B. Regarding current trading prices, PLYM-PA is priced at $24.98, while RCC trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas RCC's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to RCC's ROE of -0.31%. Regarding short-term risk, PLYM-PA is less volatile compared to RCC. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check RCC's competition here
PLYM-PA vs GRP-UN Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, GRP-UN has a market cap of 3.6B. Regarding current trading prices, PLYM-PA is priced at $24.98, while GRP-UN trades at $59.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas GRP-UN's P/E ratio is 17.21. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to GRP-UN's ROE of +0.05%. Regarding short-term risk, PLYM-PA is less volatile compared to GRP-UN. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check GRP-UN's competition here
PLYM-PA vs NSA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, NSA has a market cap of 3.5B. Regarding current trading prices, PLYM-PA is priced at $24.98, while NSA trades at $45.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas NSA's P/E ratio is 20.04. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to NSA's ROE of +0.08%. Regarding short-term risk, PLYM-PA is less volatile compared to NSA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check NSA's competition here
PLYM-PA vs LXP-PC Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, LXP-PC has a market cap of 3.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while LXP-PC trades at $46.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas LXP-PC's P/E ratio is 70.75. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to LXP-PC's ROE of +0.05%. Regarding short-term risk, PLYM-PA is less volatile compared to LXP-PC. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check LXP-PC's competition here
PLYM-PA vs LXP Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, LXP has a market cap of 3.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while LXP trades at $55.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas LXP's P/E ratio is 21.82. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to LXP's ROE of +0.05%. Regarding short-term risk, PLYM-PA is less volatile compared to LXP. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check LXP's competition here
PLYM-PA vs NYMTI Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, NYMTI has a market cap of 2.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while NYMTI trades at $25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas NYMTI's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to NYMTI's ROE of +0.11%. Regarding short-term risk, PLYM-PA is less volatile compared to NYMTI. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check NYMTI's competition here
PLYM-PA vs NSA-PA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, NSA-PA has a market cap of 2.3B. Regarding current trading prices, PLYM-PA is priced at $24.98, while NSA-PA trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas NSA-PA's P/E ratio is 25.47. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to NSA-PA's ROE of +0.08%. Regarding short-term risk, PLYM-PA is less volatile compared to NSA-PA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check NSA-PA's competition here
PLYM-PA vs DHCNI Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, DHCNI has a market cap of 2.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while DHCNI trades at $18.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas DHCNI's P/E ratio is -18.61. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to DHCNI's ROE of -0.19%. Regarding short-term risk, PLYM-PA is less volatile compared to DHCNI. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check DHCNI's competition here
PLYM-PA vs IIPR Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, IIPR has a market cap of 1.8B. Regarding current trading prices, PLYM-PA is priced at $24.98, while IIPR trades at $62.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas IIPR's P/E ratio is 8.63. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to IIPR's ROE of +0.06%. Regarding short-term risk, PLYM-PA is less volatile compared to IIPR. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check IIPR's competition here
PLYM-PA vs SCCF Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SCCF has a market cap of 1.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while SCCF trades at $24.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SCCF's P/E ratio is -399.72. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SCCF's ROE of -0.00%. Regarding short-term risk, PLYM-PA is less volatile compared to SCCF. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check SCCF's competition here
PLYM-PA vs SCCD Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SCCD has a market cap of 1.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while SCCD trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SCCD's P/E ratio is -234.22. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SCCD's ROE of -0.00%. Regarding short-term risk, PLYM-PA is less volatile compared to SCCD. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check SCCD's competition here
PLYM-PA vs SCCE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SCCE has a market cap of 1.2B. Regarding current trading prices, PLYM-PA is priced at $24.98, while SCCE trades at $24.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SCCE's P/E ratio is -233.27. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SCCE's ROE of -0.02%. Regarding short-term risk, PLYM-PA is less volatile compared to SCCE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check SCCE's competition here
PLYM-PA vs PLYM Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PLYM has a market cap of 979.2M. Regarding current trading prices, PLYM-PA is priced at $24.98, while PLYM trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PLYM's P/E ratio is 10.88. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PLYM's ROE of -0.10%. Regarding short-term risk, PLYM-PA is less volatile compared to PLYM. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PLYM's competition here
PLYM-PA vs JBGS Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, JBGS has a market cap of 892.5M. Regarding current trading prices, PLYM-PA is priced at $24.98, while JBGS trades at $15.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas JBGS's P/E ratio is 22.53. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to JBGS's ROE of -0.09%. Regarding short-term risk, PLYM-PA is less volatile compared to JBGS. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check JBGS's competition here
PLYM-PA vs TPTA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, TPTA has a market cap of 601.9M. Regarding current trading prices, PLYM-PA is priced at $24.98, while TPTA trades at $24.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas TPTA's P/E ratio is -17.74. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to TPTA's ROE of -0.27%. Regarding short-term risk, PLYM-PA is more volatile compared to TPTA. This indicates potentially higher risk in terms of short-term price fluctuations for PLYM-PA.Check TPTA's competition here
PLYM-PA vs ILPT Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, ILPT has a market cap of 580.7M. Regarding current trading prices, PLYM-PA is priced at $24.98, while ILPT trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas ILPT's P/E ratio is -10.62. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to ILPT's ROE of -0.11%. Regarding short-term risk, PLYM-PA is less volatile compared to ILPT. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check ILPT's competition here
PLYM-PA vs TPTS Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, TPTS has a market cap of 494.6M. Regarding current trading prices, PLYM-PA is priced at $24.98, while TPTS trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas TPTS's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to TPTS's ROE of N/A. Regarding short-term risk, PLYM-PA is more volatile compared to TPTS. This indicates potentially higher risk in terms of short-term price fluctuations for PLYM-PA.Check TPTS's competition here
PLYM-PA vs PSA-PP Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PSA-PP has a market cap of 377.3M. Regarding current trading prices, PLYM-PA is priced at $24.98, while PSA-PP trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PSA-PP's P/E ratio is 1.52. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PSA-PP's ROE of +0.20%. Regarding short-term risk, PLYM-PA is less volatile compared to PSA-PP. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PSA-PP's competition here
PLYM-PA vs TFSA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, TFSA has a market cap of 371.1M. Regarding current trading prices, PLYM-PA is priced at $24.98, while TFSA trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas TFSA's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to TFSA's ROE of -0.24%. Regarding short-term risk, PLYM-PA is less volatile compared to TFSA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check TFSA's competition here
PLYM-PA vs PINE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PINE has a market cap of 339M. Regarding current trading prices, PLYM-PA is priced at $24.98, while PINE trades at $20.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PINE's P/E ratio is -227.94. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PINE's ROE of +0.00%. Regarding short-term risk, PLYM-PA is less volatile compared to PINE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check PINE's competition here
PLYM-PA vs MDV Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, MDV has a market cap of 182.4M. Regarding current trading prices, PLYM-PA is priced at $24.98, while MDV trades at $17.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas MDV's P/E ratio is -353.40. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to MDV's ROE of +0.00%. Regarding short-term risk, PLYM-PA is less volatile compared to MDV. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check MDV's competition here
PLYM-PA vs AJXA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, AJXA has a market cap of 140.8M. Regarding current trading prices, PLYM-PA is priced at $24.98, while AJXA trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas AJXA's P/E ratio is 17.28. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to AJXA's ROE of -0.00%. Regarding short-term risk, PLYM-PA is less volatile compared to AJXA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check AJXA's competition here
PLYM-PA vs SCCB Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SCCB has a market cap of 116.7M. Regarding current trading prices, PLYM-PA is priced at $24.98, while SCCB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SCCB's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SCCB's ROE of -0.03%. Regarding short-term risk, PLYM-PA and SCCB have similar daily volatility (0.04).Check SCCB's competition here
PLYM-PA vs SACC Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SACC has a market cap of 99M. Regarding current trading prices, PLYM-PA is priced at $24.98, while SACC trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SACC's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SACC's ROE of -0.03%. Regarding short-term risk, PLYM-PA is less volatile compared to SACC. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check SACC's competition here
PLYM-PA vs SELF Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, SELF has a market cap of 59.5M. Regarding current trading prices, PLYM-PA is priced at $24.98, while SELF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas SELF's P/E ratio is 16.81. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to SELF's ROE of +0.04%. Regarding short-term risk, PLYM-PA is less volatile compared to SELF. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check SELF's competition here
PLYM-PA vs IIPR-PA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, IIPR-PA has a market cap of 49.1M. Regarding current trading prices, PLYM-PA is priced at $24.98, while IIPR-PA trades at $24.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas IIPR-PA's P/E ratio is 6.06. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to IIPR-PA's ROE of +0.06%. Regarding short-term risk, PLYM-PA is less volatile compared to IIPR-PA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check IIPR-PA's competition here
PLYM-PA vs CBSTF Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, CBSTF has a market cap of 14.5M. Regarding current trading prices, PLYM-PA is priced at $24.98, while CBSTF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas CBSTF's P/E ratio is -0.08. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to CBSTF's ROE of +1.89%. Regarding short-term risk, PLYM-PA is more volatile compared to CBSTF. This indicates potentially higher risk in terms of short-term price fluctuations for PLYM-PA.Check CBSTF's competition here
PLYM-PA vs PW-PA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, PW-PA has a market cap of 354.4K. Regarding current trading prices, PLYM-PA is priced at $24.98, while PW-PA trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas PW-PA's P/E ratio is -14.59. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to PW-PA's ROE of -0.31%. Regarding short-term risk, PLYM-PA is more volatile compared to PW-PA. This indicates potentially higher risk in terms of short-term price fluctuations for PLYM-PA.Check PW-PA's competition here
PLYM-PA vs QTS-PA Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, QTS-PA has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while QTS-PA trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas QTS-PA's P/E ratio is -48.33. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to QTS-PA's ROE of +0.01%. Regarding short-term risk, PLYM-PA is less volatile compared to QTS-PA. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check QTS-PA's competition here
PLYM-PA vs DRE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, DRE has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while DRE trades at $48.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas DRE's P/E ratio is 19.44. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to DRE's ROE of +0.15%. Regarding short-term risk, PLYM-PA is less volatile compared to DRE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check DRE's competition here
PLYM-PA vs MNR-PC Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, MNR-PC has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while MNR-PC trades at $25.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas MNR-PC's P/E ratio is 81.65. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to MNR-PC's ROE of +0.07%. Regarding short-term risk, PLYM-PA is less volatile compared to MNR-PC. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check MNR-PC's competition here
PLYM-PA vs QTS-PB Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, QTS-PB has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while QTS-PB trades at $172.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas QTS-PB's P/E ratio is -387.38. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to QTS-PB's ROE of +0.01%. Regarding short-term risk, PLYM-PA is less volatile compared to QTS-PB. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check QTS-PB's competition here
PLYM-PA vs QTS Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, QTS has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while QTS trades at $77.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas QTS's P/E ratio is N/A. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to QTS's ROE of +0.01%. Regarding short-term risk, PLYM-PA is less volatile compared to QTS. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check QTS's competition here
PLYM-PA vs CONE Comparison July 2026
PLYM-PA plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PLYM-PA stands at 186.6M. In comparison, CONE has a market cap of 0. Regarding current trading prices, PLYM-PA is priced at $24.98, while CONE trades at $90.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PLYM-PA currently has a P/E ratio of -27.36, whereas CONE's P/E ratio is 451.80. In terms of profitability, PLYM-PA's ROE is -0.10%, compared to CONE's ROE of +0.01%. Regarding short-term risk, PLYM-PA is less volatile compared to CONE. This indicates potentially lower risk in terms of short-term price fluctuations for PLYM-PA.Check CONE's competition here